Back to top

earnings-consensus: Archive

Zacks Equity Research

How Much Upside is Left in Cognizant (CTSH)? Wall Street Analysts Think 25.68%

The mean of analysts' price targets for Cognizant (CTSH) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CTSHPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Delta (DAL) Could Surge 25.22%: Read This Before Placing a Bet

The mean of analysts' price targets for Delta (DAL) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

DALNegative Net Change

Zacks Equity Research

Wall Street Analysts See a 38.92% Upside in Dutch Bros (BROS): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 38.9% in Dutch Bros (BROS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

BROSPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 43.7% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

OMCLNegative Net Change

Zacks Equity Research

Does Orla Mining (ORLA) Have the Potential to Rally 48.95% as Wall Street Analysts Expect?

The consensus price target hints at a 49% upside potential for Orla Mining (ORLA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ORLAPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 29.28% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?

The mean of analysts' price targets for Amylyx Pharmaceuticals (AMLX) points to a 29.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

AMLXNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 31.19% Upside in Aura Minerals (AUGO): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in Aura Minerals (AUGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

AUGOPositive Net Change

Zacks Equity Research

Casella (CWST) Earnings Expected to Grow: Should You Buy?

Casella (CWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CWSTNegative Net Change CLHPositive Net Change

Zacks Equity Research

HF Sinclair (DINO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

HF Sinclair (DINO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DINOPositive Net Change PSXPositive Net Change

Zacks Equity Research

DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DXCMPositive Net Change GKOSPositive Net Change

Zacks Equity Research

Coinbase Global, Inc. (COIN) Earnings Expected to Grow: Should You Buy?

Coinbase Global (COIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

COINPositive Net Change

Zacks Equity Research

Columbia Banking (COLB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Columbia Banking (COLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

COLBNegative Net Change CCBNegative Net Change

Zacks Equity Research

Analysts Estimate Columbia Sportswear (COLM) to Report a Decline in Earnings: What to Look Out for

Columbia Sportswear (COLM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

COLMNegative Net Change

Zacks Equity Research

Analysts Estimate Crocs (CROX) to Report a Decline in Earnings: What to Look Out for

Crocs (CROX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CROXNegative Net Change GILNegative Net Change

Zacks Equity Research

Aptiv PLC (APTV) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

APTIV HLDS LTD (APTV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

APTVPositive Net Change ALSNNegative Net Change

Zacks Equity Research

Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Biogen (BIIB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BIIBPositive Net Change

Zacks Equity Research

BJ's Restaurants (BJRI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

BJ's Restaurants (BJRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BJRINegative Net Change CMGPositive Net Change

Zacks Equity Research

Earnings Preview: Builders FirstSource (BLDR) Q3 Earnings Expected to Decline

Builders FirstSource (BLDR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BLDRPositive Net Change

Zacks Equity Research

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALNYPositive Net Change ARVNPositive Net Change

Zacks Equity Research

Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for

Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMRXNo Net Change UTHRNegative Net Change

Zacks Equity Research

Amazon (AMZN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amazon (AMZN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMZNPositive Net Change BKNGPositive Net Change

Zacks Equity Research

Apellis Pharmaceuticals, Inc. (APLS) Reports Next Week: Wall Street Expects Earnings Growth

Apellis Pharmaceuticals (APLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

APLSNegative Net Change RGENNegative Net Change

Zacks Equity Research

Acadian Asset Management (AAMI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Acadian Asset Management (AAMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AAMINegative Net Change VIRTPositive Net Change

Zacks Equity Research

Apple (AAPL) Earnings Expected to Grow: Should You Buy?

Apple (AAPL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AAPLPositive Net Change

Zacks Equity Research

Alkami Technology (ALKT) Reports Next Week: Wall Street Expects Earnings Growth

Alkami (ALKT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALKTPositive Net Change METAPositive Net Change